A double-blind, placebo-controlled, randomized phase III trial of gemcitabine (G) plus bevacizumab (B) versus gemcitabine plus placebo (P) in patients (pts) with advanced pancreatic cancer (PC): A preliminary analysis of Cancer and Leukemia Group B (CALGB
Year: 2007
Type: conference-abstract
Source: Journal of Clinical Oncology
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Keywords: advanced pancreatic cancer, gemcitabine, bevacizumab, combination chemotherapy, overall survival, futility analysis, metastatic pancreatic cancer, anti-angiogenic therapy, treatment discontinuation, unblinding, interim analysis, failure-free survival, progression-free survival, neutropenia, thrombocytopenia
Open Access status: closed
OpenAlex ID: W2339361819
